790269-68-0Relevant academic research and scientific papers
Synthesis of Butenolides via a Horner-Wadsworth-Emmons Cascading Dimerization Reaction
Everson, Jack,Kiefel, Milton J.
, p. 15226 - 15235 (2019)
The efficient synthesis of a range of structurally related butenolides has been observed while we were exploring the substrate-scope of a Horner-Wadsworth-Emmons (HWE) reaction. While aliphatic aldehydes gave the expected HWE product, aromatic aldehydes f
Methylglucoside phenylpyruvic acid Antidiabetes enolic type (by machine translation)
-
Paragraph 0084; 0101; 0102, (2016/10/31)
PROBLEM TO BE SOLVED: pharmaceutical, especially sugar normal agent, in other words, for antiobestic, before the diabetes, or diabetes, Antiobesic and/or of a mammal having X syndrome sugar is lowered to a normal value to be used as a medicine, phenylpyruvic acid and its derivatives methylglucoside antidiabetes enolic type. SOLUTION: the compound of the present invention, useful for managing hypoglycaemia, in other words, by balancing hypoglycaemia physical condition; a balanced sugar, especially of human diabete balanced helps keep the blood sugar level; by sthenia gulucose taken by cells, by lowering the value of sugar helps and, hence, to improve the recovery or tolerance; optimizing a sugar response; tolerance. Selected drawing: no (by machine translation)
ANTIDIABETIC ENOLIC GLUCOSIDE OF PHENYLPYRUVIC ACID
-
Paragraph 0123; 0124, (2013/12/03)
There is provided an antidiabetic enolic glucoside of phenylpyruvic acid and derivatives thereof for use as medicaments, especially normoglycemic agents, i.e. for lowering blood glucose levels to normal levels in mammals that are obese, pre-diabetic or ha
ANTIDIABETIC ENOLIC GLUCOSIDE OF PHENYLPYRUVIC ACID
-
Page/Page column 29, (2012/04/23)
There is provided an antidiabetic enolic glucoside of phenylpyruvic acid and derivatives thereof for use as medicaments, especially normoglycemic agents, i.e. for lowering blood glucose levels to normal levels in mammals that are obese, pre-diabetic or have diabetes, obesity and/or syndrome X.Hence the compounds of the present invention help to manage blood sugar levels, i.e. helping the body by balancing the blood sugar levels; helping to keep balanced blood glucose levels, particularly in humans with diabetes; aiding by enhancing the glucose uptake by the cells and by reducing sugar levels, thus improving or restoring the glucose tolerance; optimizing the glycemic response; normalizing the glucose tolerance.
